Ross River virus battle breakthrough

Features
Published
Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.